Edesa Biotech Inc (EDSA): Total Asset Value of Company
Edesa Biotech, Inc. (EDSA) is rapidly scaling its portfolio of anti-inflammatory and ARDS treatments as it progresses through clinical trials. A team of dermatologists and immunologists is driven to create breakthrough therapies within a flexible small-business environment. This chart illustrating the price evolution of the stock confirms that total assets equal 13.76, while the company, in collaboration with government funds, tests the EB05 molecule to combat respiratory pathologies.
Comprehensive metric breakdowns and analytics for Edesa (EDSA)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Edesa Biotech, Inc.|EDSA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Edesa Biotech Corp|EDSA - Company Aggregate Debts|Debts to Book Capitalization Edesa Biotech Corp|EDSA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Edesa Biotech
Fundamental valuation:EDSA, edesabiotech.com
Edesa Biotech, Inc. (EDSA) specializes in developing therapies for immune lung injuries supported by grants, which renders its balance sheet structure resilient to market shocks. An analysis of total asset trajectory (via ROA) allows for an assessment of the company's resource dynamics, reverse-calculated through profitability, which defines the security's investment class as a long-term asset with controlled capital dilution.
Competitors of Edesa Biotech, Inc. (EDSA)
ARGX (argenx.com) - Company Total Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Company Assets Pieris Pharma PVLA|SVRA (Savara Corp) - Company Total Assets|RIGL - Company Assets|Company Total Assets AnaptysBio, Inc.|astriatx.com (ATXS) - Total Business Assets|Company Total Assets ENGN (enGene)|Company Assets RAPT|JBIO (Aerovate Therapeutics Inc) - Aggregate Company Assets|Company Total Asset Base Aclaris Therapeutics, Inc (ACRS)|Company Total Assets KYTX (Kyverna Therapeutics)|TLSA - Company Total Assets|Cumulative Company Assets Cabaletta Bio (CABA)|VTYX - Aggregate Asset Value|Theratechnologies Inc (THTX) - Company Total Assets|Avalo Therapeutics Inc (AVTX) - Aggregate Company Assets|ELDN: Company Total Assets|Company Total Asset Base AGEN|Climb Bio - Aggregate Company Assets|Company Assets Zura Bio Ltd ZURA|Cumulative Company Assets aTyr (ATYR)|Aggregate Business Assets Adagene Inc ADAG|IMA (Ikena Oncology, Inc.) - Company Total Assets|STTK - Company Assets|EQ (equilliumbio.com) - Company Total Assets|Connect Biopharma Holdings Limited (CNTB) - Cumulative Company Assets|IMUX - Company Total Assets|Aggregate Asset Value Atara Biotherapeutics Inc (ATRA)|InflaRx N.V. (IFRX) - Cumulative Company Assets|Aggregate Asset Value x4pharma.com (XFOR)|Company Total Assets ACET|Celularity Inc - Company Total Asset Base|INmune Bio Corp (INMB) - Aggregate Company Assets|BRNS - Total Business Assets|KZR (Kezar Life Sciences) - Company Total Assets|Cumulative Company Assets sabbiotherapeutics.com|AKTX: Cumulative Company Assets|Company Total Asset Base Enlivex Therapeutics, Ltd.|Q32 Bio Inc. - Company Total Assets|Company Assets GeoVax Corp (GOVX)|IBIO - Company Total Assets|Carisma Therapeutics Inc - Total Business Assets|Aggregate Company Assets XTLB (XTL Biopharmaceuticals Ltd.)|BOLT - Company Total Asset Base|HCWB: Company Total Assets|APVO (Aptevo Therapeutics Inc.) - Company Total Assets|Aggregate Company Assets AIM ImmunoTech Inc. AIM|Total Asset Value of Company Aditxt Corp|GRI Bio (GRI) - Company Total Assets|Aggregate Asset Value XORTX Therapeutics Inc (XRTX)|Company Total Assets HIND (ReShape Lifesciences)|Revelation Biosciences Corp - Company Total Assets|Aggregate Company Assets Indaptus Therapeutics (INDP)|SCNI: Aggregate Asset Value|CALI (calcimedica.com) - Aggregate Company Assets|Affimed N.V. (AFMD) - Cumulative Company Assets|ALLK (Allakos Inc) - Company Total Assets|Company Total Assets HOOKIPA (HOOK)|IGM Biosciences, Inc. (IGMS) - Cumulative Company Assets|Aggregate Asset Value iteostherapeutics.com (ITOS)|Company Total Assets OCEA|TC BioPharm (Holdings) Plc - Company Total Asset Base|THRD: Aggregate Company Assets